CellaVision Valuation
| CLVSF Stock | USD 16.83 0.00 0.00% |
At this time, the firm appears to be fairly valued. CellaVision AB shows a prevailing Real Value of $17.41 per share. The current price of the firm is $16.83. Our model approximates the value of CellaVision AB from analyzing the firm fundamentals such as Return On Equity of 0.2, profit margin of 0.19 %, and Shares Outstanding of 23.85 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that CellaVision's price fluctuation is very steady at this time. Calculation of the real value of CellaVision AB is based on 3 months time horizon. Increasing CellaVision's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CellaVision pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CellaVision AB. Since CellaVision is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CellaVision Pink Sheet. However, CellaVision's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.83 | Real 17.41 | Hype 16.83 | Naive 16.17 |
The real value of CellaVision Pink Sheet, also known as its intrinsic value, is the underlying worth of CellaVision AB Company, which is reflected in its stock price. It is based on CellaVision's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CellaVision's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CellaVision AB helps investors to forecast how CellaVision pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CellaVision more accurately as focusing exclusively on CellaVision's fundamentals will not take into account other important factors: CellaVision Total Value Analysis
CellaVision AB is currently projected to have takeover price of 600.98 M with market capitalization of 489.43 M, debt of 0, and cash on hands of 18.51 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CellaVision fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
600.98 M | 489.43 M | 0 | 18.51 M |
CellaVision Investor Information
About 38.0% of the company shares are held by company insiders. The company last dividend was issued on the 12th of May 2022. Based on the analysis of CellaVision's profitability, liquidity, and operating efficiency, CellaVision AB is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.CellaVision Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CellaVision has an asset utilization ratio of 68.53 percent. This implies that the Company is making $0.69 for each dollar of assets. An increasing asset utilization means that CellaVision AB is more efficient with each dollar of assets it utilizes for everyday operations.CellaVision Ownership Allocation
CellaVision holds a total of 23.85 Million outstanding shares. CellaVision AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CellaVision Profitability Analysis
The company reported the revenue of 565.55 M. Net Income was 125.34 M with profit before overhead, payroll, taxes, and interest of 438.32 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CellaVision's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CellaVision and how it compares across the competition.
About CellaVision Valuation
The pink sheet valuation mechanism determines CellaVision's current worth on a weekly basis. Our valuation model uses a comparative analysis of CellaVision. We calculate exposure to CellaVision's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CellaVision's related companies.CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. CellaVision AB was incorporated in 1994 and is headquartered in Lund, Sweden. Cellavision is traded on OTC Exchange in the United States.
8 Steps to conduct CellaVision's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CellaVision's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CellaVision's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CellaVision's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CellaVision's revenue streams: Identify CellaVision's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CellaVision's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CellaVision's growth potential: Evaluate CellaVision's management, business model, and growth potential.
- Determine CellaVision's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CellaVision's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CellaVision Growth Indicators
Investing in growth stocks can be very risky. If the company such as CellaVision does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 23.9 M | |
| Quarterly Earnings Growth Y O Y | -0.185 | |
| Forward Price Earnings | 32.7869 | |
| Retained Earnings | 537.3 M |
Complementary Tools for CellaVision Pink Sheet analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |